News Headlines Article

Series of reports will analyze cost, benefit of pricey drugs
Modern Healthcare

A project announced Tuesday will compare the cost and benefit of costly drugs. The Institute for Clinical and Economic Review will begin releasing reports that will compare the clinical effectiveness of drugs, compare prices and their potential impact on the U.S. healthcare system and economy. The agency will then set a value-based benchmark for pricing. The ICER project is funded by a $5.2 million grant from the Laura and John Arnold Foundation, a private foundation that encourages evidence-based and multidisciplinary approaches to address challenges in various sectors, including education, policy and healthcare.